These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15918782)

  • 1. Overview of antiviral and anti-inflammatory treatment for severe acute respiratory syndrome.
    Chihrin S; Loutfy MR
    Expert Rev Anti Infect Ther; 2005 Apr; 3(2):251-62. PubMed ID: 15918782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro/con clinical debate: steroids are a key component in the treatment of SARS. Con: No, steroids are not a key component of the treatment regimen for SARS.
    Kargel MJ; Lapinsky SE
    Crit Care; 2004 Apr; 8(2):105-7. PubMed ID: 15515216
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe acute respiratory syndrome: a preliminary review.
    Koley TK
    J Indian Med Assoc; 2003 May; 101(5):308-10. PubMed ID: 14575220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribavirin in the treatment of severe acute respiratory syndrome (SARS).
    van Vonderen MG; Bos JC; Prins JM; Wertheim-van Dillen P; Speelman P
    Neth J Med; 2003 Jul; 61(7):238-41. PubMed ID: 14567520
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent antiviral strategies against human coronavirus-related respiratory illnesses.
    Golda A; Pyrc K
    Curr Opin Pulm Med; 2008 May; 14(3):248-53. PubMed ID: 18427249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe acute respiratory syndrome (SARS): a year in review.
    Skowronski DM; Astell C; Brunham RC; Low DE; Petric M; Roper RL; Talbot PJ; Tam T; Babiuk L
    Annu Rev Med; 2005; 56():357-81. PubMed ID: 15660517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral agents and corticosteroids in the treatment of severe acute respiratory syndrome (SARS).
    Yu WC; Hui DS; Chan-Yeung M
    Thorax; 2004 Aug; 59(8):643-5. PubMed ID: 15282381
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trials and novel pathogens: lessons learned from SARS.
    Muller MP; McGeer A; Straus SE; Hawryluck L; Gold WL
    Emerg Infect Dis; 2004 Mar; 10(3):389-94. PubMed ID: 15109402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features, pathogenesis and immunobiology of severe acute respiratory syndrome.
    Hui DS; Chan PK
    Curr Opin Pulm Med; 2008 May; 14(3):241-7. PubMed ID: 18427248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low prevalence of subclinical severe acute respiratory syndrome-associated coronavirus infection among hospital healthcare workers in Hong Kong.
    Lai TS; Keung Ng T; Seto WH; Yam L; Law KI; Chan J
    Scand J Infect Dis; 2005; 37(6-7):500-3. PubMed ID: 16012012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of corticosteroids in SARS.
    Oba Y
    N Engl J Med; 2003 May; 348(20):2034-5; author reply 2034-5. PubMed ID: 12748321
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospects of antiviral and anti-inflammatory therapy for respiratory syncytial virus infection.
    Blanco JC; Boukhvalova MS; Hemming P; Ottolini MG; Prince GA
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):945-55. PubMed ID: 16307507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk-stratified seroprevalence of severe acute respiratory syndrome coronavirus among children in Hong Kong.
    Lee PP; Wong WH; Leung GM; Chiu SS; Chan KH; Peiris JS; Lam TH; Lau YL
    Pediatrics; 2006 Jun; 117(6):e1156-62. PubMed ID: 16682490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral respiratory disease in pregnancy.
    Longman RE; Johnson TR
    Curr Opin Obstet Gynecol; 2007 Apr; 19(2):120-5. PubMed ID: 17353679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential for antiviral treatment of severe acute respiratory syndrome.
    Davidson A; Siddell S
    Curr Opin Infect Dis; 2003 Dec; 16(6):565-71. PubMed ID: 14624107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related differences in pulmonary cytokine response to respiratory syncytial virus infection: modulation by anti-inflammatory and antiviral treatment.
    Boukhvalova MS; Yim KC; Kuhn KH; Hemming JP; Prince GA; Porter DD; Blanco JC
    J Infect Dis; 2007 Feb; 195(4):511-8. PubMed ID: 17230410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical factors influencing the uses of cortisone in severe acute respiratory syndrome].
    Xie GQ; Wang GF; Wu YF; Chen BW; Xiao F; Li N; Wang YX; Han DM
    Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(13):1079-81. PubMed ID: 15312505
    [No Abstract]   [Full Text] [Related]  

  • 20. Ribavirin trials and hantavirus--what we should not conclude.
    Marcus KA; Johann-Liang R; Powers JH
    Clin Infect Dis; 2005 May; 40(10):1550-1. PubMed ID: 15844085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.